Request for Covid-19 Impact Assessment of this Report
The United States Anti-Nausea and Vomiting Healthcare Device market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Anti-Nausea and Vomiting Healthcare Device market, reaching US$ million by the year 2028. As for the Europe Anti-Nausea and Vomiting Healthcare Device landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Anti-Nausea and Vomiting Healthcare Device players cover Reliefband, EmeTerm (WAT Medical), Toulifly, and Sea-Bands, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Nausea and Vomiting Healthcare Device market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Wrist Band
Food
Inhaler
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
For Children
For Pregnant
For other people with motion sickness
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Reliefband
EmeTerm (WAT Medical)
Toulifly
Sea-Bands
MotionCure (Sidis Labs)
Quease EASE (Soothing Scents)
Blisslets
GRAVOL
Walgreens
Dramamine(Prestige Consumer Healthcare)
Psi Bands
NoMo
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Anti-Nausea and Vomiting Healthcare Device Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Anti-Nausea and Vomiting Healthcare Device by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Anti-Nausea and Vomiting Healthcare Device by Country/Region, 2017, 2022 & 2028
2.2 Anti-Nausea and Vomiting Healthcare Device Segment by Type
2.2.1 Wrist Band
2.2.2 Food
2.2.3 Inhaler
2.2.4 Others
2.3 Anti-Nausea and Vomiting Healthcare Device Sales by Type
2.3.1 Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Type (2017-2022)
2.3.2 Global Anti-Nausea and Vomiting Healthcare Device Revenue and Market Share by Type (2017-2022)
2.3.3 Global Anti-Nausea and Vomiting Healthcare Device Sale Price by Type (2017-2022)
2.4 Anti-Nausea and Vomiting Healthcare Device Segment by Application
2.4.1 For Children
2.4.2 For Pregnant
2.4.3 For other people with motion sickness
2.5 Anti-Nausea and Vomiting Healthcare Device Sales by Application
2.5.1 Global Anti-Nausea and Vomiting Healthcare Device Sale Market Share by Application (2017-2022)
2.5.2 Global Anti-Nausea and Vomiting Healthcare Device Revenue and Market Share by Application (2017-2022)
2.5.3 Global Anti-Nausea and Vomiting Healthcare Device Sale Price by Application (2017-2022)
3 Global Anti-Nausea and Vomiting Healthcare Device by Company
3.1 Global Anti-Nausea and Vomiting Healthcare Device Breakdown Data by Company
3.1.1 Global Anti-Nausea and Vomiting Healthcare Device Annual Sales by Company (2020-2022)
3.1.2 Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Company (2020-2022)
3.2 Global Anti-Nausea and Vomiting Healthcare Device Annual Revenue by Company (2020-2022)
3.2.1 Global Anti-Nausea and Vomiting Healthcare Device Revenue by Company (2020-2022)
3.2.2 Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Company (2020-2022)
3.3 Global Anti-Nausea and Vomiting Healthcare Device Sale Price by Company
3.4 Key Manufacturers Anti-Nausea and Vomiting Healthcare Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-Nausea and Vomiting Healthcare Device Product Location Distribution
3.4.2 Players Anti-Nausea and Vomiting Healthcare Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Anti-Nausea and Vomiting Healthcare Device by Geographic Region
4.1 World Historic Anti-Nausea and Vomiting Healthcare Device Market Size by Geographic Region (2017-2022)
4.1.1 Global Anti-Nausea and Vomiting Healthcare Device Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Anti-Nausea and Vomiting Healthcare Device Annual Revenue by Geographic Region
4.2 World Historic Anti-Nausea and Vomiting Healthcare Device Market Size by Country/Region (2017-2022)
4.2.1 Global Anti-Nausea and Vomiting Healthcare Device Annual Sales by Country/Region (2017-2022)
4.2.2 Global Anti-Nausea and Vomiting Healthcare Device Annual Revenue by Country/Region
4.3 Americas Anti-Nausea and Vomiting Healthcare Device Sales Growth
4.4 APAC Anti-Nausea and Vomiting Healthcare Device Sales Growth
4.5 Europe Anti-Nausea and Vomiting Healthcare Device Sales Growth
4.6 Middle East & Africa Anti-Nausea and Vomiting Healthcare Device Sales Growth
5 Americas
5.1 Americas Anti-Nausea and Vomiting Healthcare Device Sales by Country
5.1.1 Americas Anti-Nausea and Vomiting Healthcare Device Sales by Country (2017-2022)
5.1.2 Americas Anti-Nausea and Vomiting Healthcare Device Revenue by Country (2017-2022)
5.2 Americas Anti-Nausea and Vomiting Healthcare Device Sales by Type
5.3 Americas Anti-Nausea and Vomiting Healthcare Device Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-Nausea and Vomiting Healthcare Device Sales by Region
6.1.1 APAC Anti-Nausea and Vomiting Healthcare Device Sales by Region (2017-2022)
6.1.2 APAC Anti-Nausea and Vomiting Healthcare Device Revenue by Region (2017-2022)
6.2 APAC Anti-Nausea and Vomiting Healthcare Device Sales by Type
6.3 APAC Anti-Nausea and Vomiting Healthcare Device Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Anti-Nausea and Vomiting Healthcare Device by Country
7.1.1 Europe Anti-Nausea and Vomiting Healthcare Device Sales by Country (2017-2022)
7.1.2 Europe Anti-Nausea and Vomiting Healthcare Device Revenue by Country (2017-2022)
7.2 Europe Anti-Nausea and Vomiting Healthcare Device Sales by Type
7.3 Europe Anti-Nausea and Vomiting Healthcare Device Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Anti-Nausea and Vomiting Healthcare Device by Country
8.1.1 Middle East & Africa Anti-Nausea and Vomiting Healthcare Device Sales by Country (2017-2022)
8.1.2 Middle East & Africa Anti-Nausea and Vomiting Healthcare Device Revenue by Country (2017-2022)
8.2 Middle East & Africa Anti-Nausea and Vomiting Healthcare Device Sales by Type
8.3 Middle East & Africa Anti-Nausea and Vomiting Healthcare Device Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-Nausea and Vomiting Healthcare Device
10.3 Manufacturing Process Analysis of Anti-Nausea and Vomiting Healthcare Device
10.4 Industry Chain Structure of Anti-Nausea and Vomiting Healthcare Device
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-Nausea and Vomiting Healthcare Device Distributors
11.3 Anti-Nausea and Vomiting Healthcare Device Customer
12 World Forecast Review for Anti-Nausea and Vomiting Healthcare Device by Geographic Region
12.1 Global Anti-Nausea and Vomiting Healthcare Device Market Size Forecast by Region
12.1.1 Global Anti-Nausea and Vomiting Healthcare Device Forecast by Region (2023-2028)
12.1.2 Global Anti-Nausea and Vomiting Healthcare Device Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Anti-Nausea and Vomiting Healthcare Device Forecast by Type
12.7 Global Anti-Nausea and Vomiting Healthcare Device Forecast by Application
13 Key Players Analysis
13.1 Reliefband
13.1.1 Reliefband Company Information
13.1.2 Reliefband Anti-Nausea and Vomiting Healthcare Device Product Offered
13.1.3 Reliefband Anti-Nausea and Vomiting Healthcare Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Reliefband Main Business Overview
13.1.5 Reliefband Latest Developments
13.2 EmeTerm (WAT Medical)
13.2.1 EmeTerm (WAT Medical) Company Information
13.2.2 EmeTerm (WAT Medical) Anti-Nausea and Vomiting Healthcare Device Product Offered
13.2.3 EmeTerm (WAT Medical) Anti-Nausea and Vomiting Healthcare Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 EmeTerm (WAT Medical) Main Business Overview
13.2.5 EmeTerm (WAT Medical) Latest Developments
13.3 Toulifly
13.3.1 Toulifly Company Information
13.3.2 Toulifly Anti-Nausea and Vomiting Healthcare Device Product Offered
13.3.3 Toulifly Anti-Nausea and Vomiting Healthcare Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Toulifly Main Business Overview
13.3.5 Toulifly Latest Developments
13.4 Sea-Bands
13.4.1 Sea-Bands Company Information
13.4.2 Sea-Bands Anti-Nausea and Vomiting Healthcare Device Product Offered
13.4.3 Sea-Bands Anti-Nausea and Vomiting Healthcare Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Sea-Bands Main Business Overview
13.4.5 Sea-Bands Latest Developments
13.5 MotionCure (Sidis Labs)
13.5.1 MotionCure (Sidis Labs) Company Information
13.5.2 MotionCure (Sidis Labs) Anti-Nausea and Vomiting Healthcare Device Product Offered
13.5.3 MotionCure (Sidis Labs) Anti-Nausea and Vomiting Healthcare Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 MotionCure (Sidis Labs) Main Business Overview
13.5.5 MotionCure (Sidis Labs) Latest Developments
13.6 Quease EASE (Soothing Scents)
13.6.1 Quease EASE (Soothing Scents) Company Information
13.6.2 Quease EASE (Soothing Scents) Anti-Nausea and Vomiting Healthcare Device Product Offered
13.6.3 Quease EASE (Soothing Scents) Anti-Nausea and Vomiting Healthcare Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Quease EASE (Soothing Scents) Main Business Overview
13.6.5 Quease EASE (Soothing Scents) Latest Developments
13.7 Blisslets
13.7.1 Blisslets Company Information
13.7.2 Blisslets Anti-Nausea and Vomiting Healthcare Device Product Offered
13.7.3 Blisslets Anti-Nausea and Vomiting Healthcare Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Blisslets Main Business Overview
13.7.5 Blisslets Latest Developments
13.8 GRAVOL
13.8.1 GRAVOL Company Information
13.8.2 GRAVOL Anti-Nausea and Vomiting Healthcare Device Product Offered
13.8.3 GRAVOL Anti-Nausea and Vomiting Healthcare Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 GRAVOL Main Business Overview
13.8.5 GRAVOL Latest Developments
13.9 Walgreens
13.9.1 Walgreens Company Information
13.9.2 Walgreens Anti-Nausea and Vomiting Healthcare Device Product Offered
13.9.3 Walgreens Anti-Nausea and Vomiting Healthcare Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Walgreens Main Business Overview
13.9.5 Walgreens Latest Developments
13.10 Dramamine(Prestige Consumer Healthcare)
13.10.1 Dramamine(Prestige Consumer Healthcare) Company Information
13.10.2 Dramamine(Prestige Consumer Healthcare) Anti-Nausea and Vomiting Healthcare Device Product Offered
13.10.3 Dramamine(Prestige Consumer Healthcare) Anti-Nausea and Vomiting Healthcare Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Dramamine(Prestige Consumer Healthcare) Main Business Overview
13.10.5 Dramamine(Prestige Consumer Healthcare) Latest Developments
13.11 Psi Bands
13.11.1 Psi Bands Company Information
13.11.2 Psi Bands Anti-Nausea and Vomiting Healthcare Device Product Offered
13.11.3 Psi Bands Anti-Nausea and Vomiting Healthcare Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Psi Bands Main Business Overview
13.11.5 Psi Bands Latest Developments
13.12 NoMo
13.12.1 NoMo Company Information
13.12.2 NoMo Anti-Nausea and Vomiting Healthcare Device Product Offered
13.12.3 NoMo Anti-Nausea and Vomiting Healthcare Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 NoMo Main Business Overview
13.12.5 NoMo Latest Developments
14 Research Findings and Conclusion
Table 1. Anti-Nausea and Vomiting Healthcare Device Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Anti-Nausea and Vomiting Healthcare Device Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Wrist Band
Table 4. Major Players of Food
Table 5. Major Players of Inhaler
Table 6. Major Players of Others
Table 7. Global Anti-Nausea and Vomiting Healthcare Device Sales by Type (2017-2022) & (K Units)
Table 8. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Type (2017-2022)
Table 9. Global Anti-Nausea and Vomiting Healthcare Device Revenue by Type (2017-2022) & ($ million)
Table 10. Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Type (2017-2022)
Table 11. Global Anti-Nausea and Vomiting Healthcare Device Sale Price by Type (2017-2022) & (US$/Unit)
Table 12. Global Anti-Nausea and Vomiting Healthcare Device Sales by Application (2017-2022) & (K Units)
Table 13. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Application (2017-2022)
Table 14. Global Anti-Nausea and Vomiting Healthcare Device Revenue by Application (2017-2022)
Table 15. Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Application (2017-2022)
Table 16. Global Anti-Nausea and Vomiting Healthcare Device Sale Price by Application (2017-2022) & (US$/Unit)
Table 17. Global Anti-Nausea and Vomiting Healthcare Device Sales by Company (2020-2022) & (K Units)
Table 18. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Company (2020-2022)
Table 19. Global Anti-Nausea and Vomiting Healthcare Device Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Company (2020-2022)
Table 21. Global Anti-Nausea and Vomiting Healthcare Device Sale Price by Company (2020-2022) & (US$/Unit)
Table 22. Key Manufacturers Anti-Nausea and Vomiting Healthcare Device Producing Area Distribution and Sales Area
Table 23. Players Anti-Nausea and Vomiting Healthcare Device Products Offered
Table 24. Anti-Nausea and Vomiting Healthcare Device Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Anti-Nausea and Vomiting Healthcare Device Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share Geographic Region (2017-2022)
Table 29. Global Anti-Nausea and Vomiting Healthcare Device Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Anti-Nausea and Vomiting Healthcare Device Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Country/Region (2017-2022)
Table 33. Global Anti-Nausea and Vomiting Healthcare Device Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Anti-Nausea and Vomiting Healthcare Device Sales by Country (2017-2022) & (K Units)
Table 36. Americas Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Country (2017-2022)
Table 37. Americas Anti-Nausea and Vomiting Healthcare Device Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Country (2017-2022)
Table 39. Americas Anti-Nausea and Vomiting Healthcare Device Sales by Type (2017-2022) & (K Units)
Table 40. Americas Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Type (2017-2022)
Table 41. Americas Anti-Nausea and Vomiting Healthcare Device Sales by Application (2017-2022) & (K Units)
Table 42. Americas Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Application (2017-2022)
Table 43. APAC Anti-Nausea and Vomiting Healthcare Device Sales by Region (2017-2022) & (K Units)
Table 44. APAC Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Region (2017-2022)
Table 45. APAC Anti-Nausea and Vomiting Healthcare Device Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Region (2017-2022)
Table 47. APAC Anti-Nausea and Vomiting Healthcare Device Sales by Type (2017-2022) & (K Units)
Table 48. APAC Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Type (2017-2022)
Table 49. APAC Anti-Nausea and Vomiting Healthcare Device Sales by Application (2017-2022) & (K Units)
Table 50. APAC Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Application (2017-2022)
Table 51. Europe Anti-Nausea and Vomiting Healthcare Device Sales by Country (2017-2022) & (K Units)
Table 52. Europe Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Country (2017-2022)
Table 53. Europe Anti-Nausea and Vomiting Healthcare Device Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Country (2017-2022)
Table 55. Europe Anti-Nausea and Vomiting Healthcare Device Sales by Type (2017-2022) & (K Units)
Table 56. Europe Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Type (2017-2022)
Table 57. Europe Anti-Nausea and Vomiting Healthcare Device Sales by Application (2017-2022) & (K Units)
Table 58. Europe Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Anti-Nausea and Vomiting Healthcare Device Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Anti-Nausea and Vomiting Healthcare Device Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Anti-Nausea and Vomiting Healthcare Device Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Anti-Nausea and Vomiting Healthcare Device Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Anti-Nausea and Vomiting Healthcare Device
Table 68. Key Market Challenges & Risks of Anti-Nausea and Vomiting Healthcare Device
Table 69. Key Industry Trends of Anti-Nausea and Vomiting Healthcare Device
Table 70. Anti-Nausea and Vomiting Healthcare Device Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Anti-Nausea and Vomiting Healthcare Device Distributors List
Table 73. Anti-Nausea and Vomiting Healthcare Device Customer List
Table 74. Global Anti-Nausea and Vomiting Healthcare Device Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Forecast by Region
Table 76. Global Anti-Nausea and Vomiting Healthcare Device Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Anti-Nausea and Vomiting Healthcare Device Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas Anti-Nausea and Vomiting Healthcare Device Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Anti-Nausea and Vomiting Healthcare Device Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC Anti-Nausea and Vomiting Healthcare Device Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Anti-Nausea and Vomiting Healthcare Device Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe Anti-Nausea and Vomiting Healthcare Device Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Anti-Nausea and Vomiting Healthcare Device Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa Anti-Nausea and Vomiting Healthcare Device Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Anti-Nausea and Vomiting Healthcare Device Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Anti-Nausea and Vomiting Healthcare Device Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Anti-Nausea and Vomiting Healthcare Device Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Anti-Nausea and Vomiting Healthcare Device Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share Forecast by Application (2023-2028)
Table 94. Reliefband Basic Information, Anti-Nausea and Vomiting Healthcare Device Manufacturing Base, Sales Area and Its Competitors
Table 95. Reliefband Anti-Nausea and Vomiting Healthcare Device Product Offered
Table 96. Reliefband Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 97. Reliefband Main Business
Table 98. Reliefband Latest Developments
Table 99. EmeTerm (WAT Medical) Basic Information, Anti-Nausea and Vomiting Healthcare Device Manufacturing Base, Sales Area and Its Competitors
Table 100. EmeTerm (WAT Medical) Anti-Nausea and Vomiting Healthcare Device Product Offered
Table 101. EmeTerm (WAT Medical) Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 102. EmeTerm (WAT Medical) Main Business
Table 103. EmeTerm (WAT Medical) Latest Developments
Table 104. Toulifly Basic Information, Anti-Nausea and Vomiting Healthcare Device Manufacturing Base, Sales Area and Its Competitors
Table 105. Toulifly Anti-Nausea and Vomiting Healthcare Device Product Offered
Table 106. Toulifly Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 107. Toulifly Main Business
Table 108. Toulifly Latest Developments
Table 109. Sea-Bands Basic Information, Anti-Nausea and Vomiting Healthcare Device Manufacturing Base, Sales Area and Its Competitors
Table 110. Sea-Bands Anti-Nausea and Vomiting Healthcare Device Product Offered
Table 111. Sea-Bands Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 112. Sea-Bands Main Business
Table 113. Sea-Bands Latest Developments
Table 114. MotionCure (Sidis Labs) Basic Information, Anti-Nausea and Vomiting Healthcare Device Manufacturing Base, Sales Area and Its Competitors
Table 115. MotionCure (Sidis Labs) Anti-Nausea and Vomiting Healthcare Device Product Offered
Table 116. MotionCure (Sidis Labs) Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 117. MotionCure (Sidis Labs) Main Business
Table 118. MotionCure (Sidis Labs) Latest Developments
Table 119. Quease EASE (Soothing Scents) Basic Information, Anti-Nausea and Vomiting Healthcare Device Manufacturing Base, Sales Area and Its Competitors
Table 120. Quease EASE (Soothing Scents) Anti-Nausea and Vomiting Healthcare Device Product Offered
Table 121. Quease EASE (Soothing Scents) Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 122. Quease EASE (Soothing Scents) Main Business
Table 123. Quease EASE (Soothing Scents) Latest Developments
Table 124. Blisslets Basic Information, Anti-Nausea and Vomiting Healthcare Device Manufacturing Base, Sales Area and Its Competitors
Table 125. Blisslets Anti-Nausea and Vomiting Healthcare Device Product Offered
Table 126. Blisslets Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 127. Blisslets Main Business
Table 128. Blisslets Latest Developments
Table 129. GRAVOL Basic Information, Anti-Nausea and Vomiting Healthcare Device Manufacturing Base, Sales Area and Its Competitors
Table 130. GRAVOL Anti-Nausea and Vomiting Healthcare Device Product Offered
Table 131. GRAVOL Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 132. GRAVOL Main Business
Table 133. GRAVOL Latest Developments
Table 134. Walgreens Basic Information, Anti-Nausea and Vomiting Healthcare Device Manufacturing Base, Sales Area and Its Competitors
Table 135. Walgreens Anti-Nausea and Vomiting Healthcare Device Product Offered
Table 136. Walgreens Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 137. Walgreens Main Business
Table 138. Walgreens Latest Developments
Table 139. Dramamine(Prestige Consumer Healthcare) Basic Information, Anti-Nausea and Vomiting Healthcare Device Manufacturing Base, Sales Area and Its Competitors
Table 140. Dramamine(Prestige Consumer Healthcare) Anti-Nausea and Vomiting Healthcare Device Product Offered
Table 141. Dramamine(Prestige Consumer Healthcare) Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 142. Dramamine(Prestige Consumer Healthcare) Main Business
Table 143. Dramamine(Prestige Consumer Healthcare) Latest Developments
Table 144. Psi Bands Basic Information, Anti-Nausea and Vomiting Healthcare Device Manufacturing Base, Sales Area and Its Competitors
Table 145. Psi Bands Anti-Nausea and Vomiting Healthcare Device Product Offered
Table 146. Psi Bands Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 147. Psi Bands Main Business
Table 148. Psi Bands Latest Developments
Table 149. NoMo Basic Information, Anti-Nausea and Vomiting Healthcare Device Manufacturing Base, Sales Area and Its Competitors
Table 150. NoMo Anti-Nausea and Vomiting Healthcare Device Product Offered
Table 151. NoMo Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 152. NoMo Main Business
Table 153. NoMo Latest Developments
List of Figures
Figure 1. Picture of Anti-Nausea and Vomiting Healthcare Device
Figure 2. Anti-Nausea and Vomiting Healthcare Device Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-Nausea and Vomiting Healthcare Device Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Anti-Nausea and Vomiting Healthcare Device Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Anti-Nausea and Vomiting Healthcare Device Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Wrist Band
Figure 10. Product Picture of Food
Figure 11. Product Picture of Inhaler
Figure 12. Product Picture of Others
Figure 13. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Type in 2021
Figure 14. Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Type (2017-2022)
Figure 15. Anti-Nausea and Vomiting Healthcare Device Consumed in For Children
Figure 16. Global Anti-Nausea and Vomiting Healthcare Device Market: For Children (2017-2022) & (K Units)
Figure 17. Anti-Nausea and Vomiting Healthcare Device Consumed in For Pregnant
Figure 18. Global Anti-Nausea and Vomiting Healthcare Device Market: For Pregnant (2017-2022) & (K Units)
Figure 19. Anti-Nausea and Vomiting Healthcare Device Consumed in For other people with motion sickness
Figure 20. Global Anti-Nausea and Vomiting Healthcare Device Market: For other people with motion sickness (2017-2022) & (K Units)
Figure 21. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Application (2017-2022)
Figure 22. Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Application in 2021
Figure 23. Anti-Nausea and Vomiting Healthcare Device Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Company in 2021
Figure 25. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Geographic Region in 2021
Figure 27. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Region (2017-2022)
Figure 28. Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Country/Region in 2021
Figure 29. Americas Anti-Nausea and Vomiting Healthcare Device Sales 2017-2022 (K Units)
Figure 30. Americas Anti-Nausea and Vomiting Healthcare Device Revenue 2017-2022 ($ Millions)
Figure 31. APAC Anti-Nausea and Vomiting Healthcare Device Sales 2017-2022 (K Units)
Figure 32. APAC Anti-Nausea and Vomiting Healthcare Device Revenue 2017-2022 ($ Millions)
Figure 33. Europe Anti-Nausea and Vomiting Healthcare Device Sales 2017-2022 (K Units)
Figure 34. Europe Anti-Nausea and Vomiting Healthcare Device Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Anti-Nausea and Vomiting Healthcare Device Sales 2017-2022 (K Units)
Figure 36. Middle East & Africa Anti-Nausea and Vomiting Healthcare Device Revenue 2017-2022 ($ Millions)
Figure 37. Americas Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Country in 2021
Figure 38. Americas Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Country in 2021
Figure 39. United States Anti-Nausea and Vomiting Healthcare Device Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Anti-Nausea and Vomiting Healthcare Device Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Anti-Nausea and Vomiting Healthcare Device Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Anti-Nausea and Vomiting Healthcare Device Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Region in 2021
Figure 44. APAC Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Regions in 2021
Figure 45. China Anti-Nausea and Vomiting Healthcare Device Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Anti-Nausea and Vomiting Healthcare Device Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Anti-Nausea and Vomiting Healthcare Device Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Anti-Nausea and Vomiting Healthcare Device Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Anti-Nausea and Vomiting Healthcare Device Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Anti-Nausea and Vomiting Healthcare Device Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Country in 2021
Figure 52. Europe Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Country in 2021
Figure 53. Germany Anti-Nausea and Vomiting Healthcare Device Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Anti-Nausea and Vomiting Healthcare Device Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Anti-Nausea and Vomiting Healthcare Device Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Anti-Nausea and Vomiting Healthcare Device Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Anti-Nausea and Vomiting Healthcare Device Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Country in 2021
Figure 60. Egypt Anti-Nausea and Vomiting Healthcare Device Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Anti-Nausea and Vomiting Healthcare Device Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Anti-Nausea and Vomiting Healthcare Device Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Anti-Nausea and Vomiting Healthcare Device Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Anti-Nausea and Vomiting Healthcare Device Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Anti-Nausea and Vomiting Healthcare Device in 2021
Figure 66. Manufacturing Process Analysis of Anti-Nausea and Vomiting Healthcare Device
Figure 67. Industry Chain Structure of Anti-Nausea and Vomiting Healthcare Device
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...